Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
Clinical trial NCT02080416 · TERMINATED
Trial details
- NCT number
- NCT02080416
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-02-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.